Flexion Therapeutics: 2Q Earnings Snapshot
BURLINGTON, Mass. (AP) _ Flexion Therapeutics Inc. (FLXN) on Tuesday reported a loss of $36.5 million in its second quarter.
The Burlington, Massachusetts-based company said it had a loss of 96 cents per share.
The results beat Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $1.06 per share.
The specialty pharmaceutical companies that specializes in pain relief posted revenue of $17 million in the period, also topping Street forecasts. Three analysts surveyed by Zacks expected $14 million.
Flexion Therapeutics shares have decreased 19% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $9.14, a decrease of 60% in the last 12 months.